Sleep

Association of accelerometer-derived sleep characteristics with incident osteoporosis: a prospective cohort study from the UK Biobank.

TL;DR

Longer objective sleep duration, higher sleep efficiency, and stronger relative amplitude were independently associated with a lower risk of incident osteoporosis in a large prospective cohort study.

Key Findings

Longer average sleep duration was associated with a significantly reduced risk of incident osteoporosis.

  • HR = 0.91, 95% CI: 0.87–0.95; P < 0.001
  • Sleep duration was derived from 7 consecutive days of wrist accelerometer data in 72,211 UK Biobank participants
  • Multivariable Cox proportional hazards models were used to examine the association
  • Restricted cubic spline analysis showed no significant nonlinear relationship (P nonlinear > 0.05)

Higher sleep efficiency was associated with a significantly reduced risk of incident osteoporosis.

  • HR = 0.92, 95% CI: 0.88–0.97; P = 0.001
  • Sleep efficiency was one of five objective sleep metrics derived from accelerometer data
  • The association remained significant in multivariable Cox proportional hazards models
  • No significant nonlinear relationship was detected via restricted cubic splines (P nonlinear > 0.05)

Stronger relative amplitude (a measure of rest-activity rhythmicity) was associated with a substantially reduced risk of incident osteoporosis.

  • HR = 0.80, 95% CI: 0.76–0.85; P < 0.001
  • Relative amplitude had the largest magnitude of association among the five sleep metrics examined
  • No significant nonlinear relationship was detected via restricted cubic splines (P nonlinear > 0.05)
  • Relative amplitude reflects the contrast between the most active and least active periods of the day-night cycle

Sleep regularity index and sleep midpoint were not reported as significantly associated with osteoporosis risk in the main analysis.

  • Five objective sleep metrics were assessed: sleep duration, sleep efficiency, sleep regularity index, sleep midpoint, and relative amplitude
  • Only sleep duration, sleep efficiency, and relative amplitude showed significant associations with reduced OP risk
  • All metrics were derived from 7 consecutive days of wrist accelerometer data

A significant negative interaction was found between relative amplitude and sleep duration in relation to osteoporosis risk.

  • Interaction HR = 0.96, 95% CI: 0.93–0.99; P = 0.012
  • This indicates that the association between sleep duration and OP risk varied depending on the level of relative amplitude
  • The interaction was identified through formal interaction analysis within the Cox proportional hazards framework

Sex-stratified analyses revealed that in women the associations mirrored the main analysis, while in men only sleep duration and relative amplitude were significantly associated with lower osteoporosis risk.

  • In women, sleep duration, sleep efficiency, and relative amplitude were all significantly associated with lower OP risk, consistent with the overall findings
  • In men, only sleep duration and relative amplitude were significantly associated with lower OP risk (all P < 0.05)
  • Sleep efficiency was not significantly associated with OP risk in men
  • Sex-stratified subgroup analyses were conducted based on interaction analysis results

The study included 72,211 UK Biobank participants who provided 7 consecutive days of wrist accelerometer data, with incident osteoporosis identified through linkage with electronic medical records.

  • This was a prospective cohort study design
  • Objective sleep metrics included: sleep duration, sleep efficiency, sleep regularity index, sleep midpoint, and relative amplitude
  • Incident OP events were ascertained via linkage to electronic medical records
  • Multivariable Cox proportional hazards models and restricted cubic splines were the primary analytical tools

What This Means

This research suggests that how well and how long people sleep — measured objectively using wrist-worn activity trackers — is linked to their likelihood of developing osteoporosis (a disease that weakens bones). Using data from over 72,000 UK Biobank participants tracked over time, researchers found that people who slept longer, slept more efficiently, and had stronger day-night activity rhythms were meaningfully less likely to develop osteoporosis. Importantly, rather than relying on people's own reports of their sleep, the study used seven days of continuous wrist accelerometer recordings to capture objective sleep patterns across multiple dimensions. One particularly notable finding is that 'relative amplitude' — a measure of how distinctly a person's activity is concentrated in the daytime versus nighttime — showed the strongest association with lower osteoporosis risk, with people in higher relative amplitude categories having about 20% lower risk. The study also found that the protective association of longer sleep duration was influenced by a person's relative amplitude level, suggesting these sleep dimensions interact with each other. When results were broken down by sex, women showed associations across sleep duration, efficiency, and relative amplitude, while in men only sleep duration and relative amplitude remained statistically significant. This research suggests that multiple dimensions of sleep health, particularly the contrast between rest and activity across the day-night cycle, may be relevant to bone health and osteoporosis risk. However, the authors caution that this is an observational study and cannot prove that poor sleep causes osteoporosis — further research is needed to understand the underlying mechanisms and whether improving sleep could actually reduce osteoporosis risk.

Check Your Own Numbers

Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.

Upload Your Labs

Have a question about this study?

Citation

Hu Z, Wang G, Kong X, Jia J, Zhao M, Deng J, et al.. (2026). Association of accelerometer-derived sleep characteristics with incident osteoporosis: a prospective cohort study from the UK Biobank.. Frontiers in endocrinology. https://doi.org/10.3389/fendo.2026.1818773